Skip to main content
    H

    High Tide Inc (HITI)

    Official site

    HEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ

    $2.37
    -0.10 (-4.05%)

    Market Cap: $220.18M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    High Tide Inc (HITI) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    High Tide (HITI) trades at 0.4x sales and 3.0x book value. Its P/S of 0.4x is in line with its 5-year median.

    Current Multiples

    HITI reports in CAD, so earnings multiples appear here only when its per-share earnings can be confirmed. Its free cash flow yield is 5.1%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales0.4x
    Price to book3.0x
    EV/EBITDA69.7x
    Price to FCF19.5x
    EV/FCF22.2x
    PEGN/A
    FCF yield5.1%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S0.4x0.4xN/A
    P/B3.0x1.8xN/A
    Medians of month-end values through Oct 2026: 55 to 60 months (5-year).

    Valuation History

    Over the 4 of the 7 year ends shown that have a P/S, its P/S ranged from 0.3x in 2023 to 0.6x in 2024.

    Year endPriceP/SP/B
    2025$2.650.5x3.7x
    2024$3.090.6x2.4x
    2023$1.630.3x1.3x
    2022$1.540.4x1.0x
    2021$4.25N/A2.1x
    2020$3.00N/AN/A
    2019$2.04N/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HITI

    Is HITI stock overvalued?

    GNG's valuation label for HITI is Fairly valued.

    What is HITI's price to sales ratio?

    High Tide has a price to sales ratio of 0.4x.